PACIFIC BIOSCIENCES CALIFORNIA INC

PACB NASDAQ

Juliac

Recently there are many small stocks that broke out of a long term base spanning 2 years or more. How do we identify penny stocks with good odds of being a multi-bagger? PACB is one such example with the right criteria that increased it's odds of having a trend that is sustainable to great extends. Criteria: 1. long term base/bottoming formation (preferably 2...

AptitudeFinancialAdvisory

Pacific Biosciences of California is a biotech company that develops and manufactures systems for gene sequencing and is currently the largest position in the ARK Genomic Revolution ETF which is the best performing ETF for ARK. The next big change to healthcare will be the ability to eliminate genetic diseases and prevent certain cancers due to the ability to...

SimplyCash

A well-needed healthy pullback occurred and touched the 50SMA - should see money pouring back in for the January effect around the corner. An $ARKG favorite with a heavy weighting in their portfolio. Perfect opportunity for sideliners to have taken a position today. Good luck!

allthesmokeacquisitioncompany

large volume large price increase and initial breakout price target 20-25% higher from current price. I own this stock after holding support at the 10day moving average. the fundamentals of genomic testing and widespread adoption is a significant trend driving change in the healthcare industry.

Techreturns

Called this out at $20.40 when wedge broke up, $PACB is a strong long term holding. Has run up massively this year but probably has more room to go, especially in the long term. A note on the two trendines. I had alerts on both these trendines. Why? It's a messy but clear downward wedge on a high beta, small cap. The 'way' that PACB (and the entire genomics...

HeWhoMustNotBeNamed

Clear uptrend despite regular retracements up to 50%. Can it go another level up? Will wait and see.

meure

PACB OCTAVE Early 2020 Range as Base

BenKnee

Bear pennant? possibly targeting $9.58 if it breaks to the downside looks like moving averages about to cross on 1hour (Death cross)

Shivakalp

Chart looks good now! UPTREND!

AngusMcK

Pacific Biosciences provides an integrated platform for genetic analysis and its sequencing systems are in use by scientists around the world to drive discovery in human biomedical research, plant and animal sciences, and microbiology. Has had a nice steady run and seems to be able to stay within a tighter 12% trail. RSI is pretty high so if you are looking for an...

st0nkz

Love this company and NNOX, both disruptors in their own respective spaces.

Vibranium_Capital

im not bullish here, so close to a big monthly resistance. just wait a couple more dollars if you arent in yet...see if it breaks or not! gl

richymag101

Added today. Looking strong for next few months at least + 220 call options vs 0 put options..

audamir

Buying opportunity when price breaks above the top trend line.

PennyStock101

Pacific Biosciences of California, Inc. PACB reported fourth-quarter 2019 break-even earnings per share (EPS) versus the Zacks Consensus Estimate of a loss of 16 cents. The company had reported a loss of 21 cents in the year-ago quarter. Revenues of this Zacks Rank #3 (Hold) company totaled $27.93 million, which outpaced the Zacks Consensus Estimate by 9.8%....

brett701

Momentum is shifting down. We have multiple gaps to fill and very decent support. If we miss the short we can take longs at the red horizontal lines.

zerrow

long

AdamNo_L

PACB is on a tear right now with new of an acquisition deal by their competitor Illumina for 1.2 billion dollars. According to Forbes, this is the largest deal Illumina has ever made in more than 20 years. According to other reports the deal won't be finalized till mid-2019 though, so today's price increase seems to a result of that new breaking yesterday after...